Oncology The Role of Biomarkers in Treatment Selection for Patients With HR+ HER2- Metastatic Breast Cancer expert roundtables By Joseph A. Sparano, MD, FACP; Matthew P. Goetz, MD; Susan Dent, MD
Oncology Advances in the Treatment of HR+ HER2- Breast Cancer expert roundtables By Joseph A. Sparano, MD, FACP; Matthew P. Goetz, MD; Susan Dent, MD
Ophthalmology Retinal Imaging in Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema: Advancements in Screening and Monitoring expert roundtables By Peter Campochiaro, MD; Peter K. Kaiser, MD; SriniVas R. Sadda, MD, FARVO
Nephrology Novel Approaches to Complement-Driven Renal Disease expert roundtables By Carla M. Nester, MD, MSA, FASN; Jai Radhakrishnan, MD, MS; Richard Lafayette, MD, FACP
Oncology Prophylactic Strategies in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation expert roundtables By John Koreth, MBBS, DPhil; Robert S. Negrin, MD; Sergio A. Giralt, MD